arrow
W

Wendy A. Woodward

the university of texas
H指数:78
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Definitive, stereotactic ablative radiotherapy and endocrine therapy without surgery for select low-risk breast cancers: A prospective, phase II trial

对于选择性低风险乳腺癌,采用立体定向消融放射治疗和内分泌治疗替代手术:一项前瞻性、II期临床试验

2026-05-150
PRE
Cholesterol efflux protein; ABCA1; supports anticancer functions of myeloid immune cells

胆固醇外流蛋白;ABCA1;支持髓系免疫细胞的抗癌功能

2026-01-010
PRE
Retrospective review of metastatic hormone receptor-positive inflammatory breast cancer patients reveals poor responses to cyclin dependent kinase 4/6 inhibition

回顾性分析显示,激素受体阳性转移性炎性乳腺癌患者对细胞周期依赖性激酶4/6抑制剂的应答不佳。

2025-12-100
OAAI
Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective study

新辅助HER2靶向方案联合或未联合蒽环类药物用于HER2阳性炎性乳腺癌:一项多中心回顾性研究

2025-08-020
PRE
The impact of breast radiotherapy on the tumor genome and immune ecosystem

乳腺癌放射治疗对肿瘤基因组和免疫生态系统的影响

2025-05-010
OA
Development of a multi-institutional dataset to validate a novel inflammatory breast cancer diagnostic score

开发一个多机构数据集以验证一种新型炎性乳腺癌诊断评分

2025-03-310
PRE
Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase 2 Trial
2025-03-010
PRE
PRECISE: Preoperative Radiation Therapy to Elicit Critical Immune Stimulating Effects-A Phase 2 Clinical Trial
2025-01-010
PRE
Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study

转移性三阴性炎性乳腺癌患者的免疫检查点抑制剂 (integrle): 一项国际队列研究

2024-12-010
PRE
Immune checkpoint inhibitors for triple-negative inflammatory breast cancer (INCORPORATE): an international multicenter retrospective analysis
2024-05-020
PRE
Pathological complete response with chemotherapy and immune checkpoint inhibition in triple negative inflammatory breast cancer (TN-IBC)
2024-05-020
PRE